Hiroshi Yamagami
Overview
Explore the profile of Hiroshi Yamagami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
256
Citations
2345
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fujiwara S, Uchida K, Ohta T, Ohara N, Kawamoto M, Yamagami H, et al.
Neurosurgery
. 2025 Mar;
96(4):824-831.
PMID: 40085506
Background And Objectives: Endovascular treatment (EVT) for medium vessel occlusion (MeVO) raises concern about hemorrhagic complications; however, its clinical impact has not been elucidated. Therefore, we investigated the association between...
2.
Taguchi A, Aso S, Yamagami H, Yasunaga H
Acute Med Surg
. 2025 Mar;
12(1):e70050.
PMID: 40041116
Aim: In Japan, emergency medical service personnel often have difficulty obtaining hospitals' acceptance of emergency cases owing to congestion in the emergency unit; such cases are called difficult-to-transport cases. Increased...
3.
Hosoo H, Imamura H, Sakai N, Iihara K, Ishii A, Sakai C, et al.
Interv Neuroradiol
. 2025 Mar;
:15910199251323003.
PMID: 40025746
Background: This study aimed to evaluate the periprocedural and postprocedural outcomes of endovascular treatments for cerebral vasospasm after subarachnoid hemorrhage using data from the Japan Registry of Neuroendovascular Therapy 4...
4.
Fujiwara S, Uchida K, Ohta T, Ohara N, Kawamoto M, Yamagami H, et al.
J Stroke
. 2025 Feb;
27(1):149-153.
PMID: 39916468
No abstract available.
5.
Yoshimoto T, Yamagami H, Matsumaru Y
Genes (Basel)
. 2025 Jan;
16(1).
PMID: 39858606
Background/objectives: Recent advances in stroke genetics have substantially enhanced our understanding of the complex genetic architecture underlying cerebral infarction and other stroke subtypes. As knowledge in this field expands, healthcare...
6.
Nasreldein A, Asyraf W, Wan Asyraf W, Nguyen T, Martins S, Martins S, et al.
Int J Stroke
. 2025 Jan;
:17474930251314395.
PMID: 39773209
Background: Mechanical thrombectomy (MT) is the standard of care for eligible acute ischemic stroke (AIS) patients with large vessel occlusion (LVO) since 2015. Aim: Our aim was to determine the...
7.
Miyamoto S, Hayakawa M, Tsuruta W, Shirakawa M, Beppu M, Sakai N, et al.
J Clin Neurosci
. 2024 Dec;
133:111014.
PMID: 39733650
Re-occlusion and intravascular thrombus formation following mechanical thrombectomy (MT) in stroke patients worsen clinical outcomes. Although early administration of antiplatelet therapy (APT) prevents these complications, current guidelines advise against using...
8.
Yoshimoto T, Yamagami H, Sakai N, Uchida K, Shirakawa M, Beppu M, et al.
Front Neurol
. 2024 Dec;
15:1475882.
PMID: 39639991
Background: We aimed to clarify the association between intraoperative P2Y inhibitor administration during EVT and clinical outcomes in patients with anterior circulation TO stroke. Methods: Among consecutive patients with acute...
9.
Yoshimoto T, Saito S, Omae K, Tanaka K, Kita T, Kitamura K, et al.
EClinicalMedicine
. 2024 Dec;
77:102901.
PMID: 39618942
Background: Adrenomedullin has angiogenic and vasoprotective effects in acute ischemic stroke (AIS). This investigator-initiated trial aimed to evaluate the safety, efficacy, and optimal administration of adrenomedullin in treating AIS. Methods:...
10.
Yamagami H, Ozaki T, Ogasawara K, Nagata I, Matsumaru Y, Yoshimura S, et al.
Stroke
. 2024 Nov;
55(12):2776-2785.
PMID: 39585936
Background: Restenosis after carotid artery stenting (CAS) is associated with the risk of developing ischemic stroke. We aimed to evaluate the inhibitory effect of cilostazol addition on in-stent restenosis (ISR)...